Drug intelligence / Profile preview

qinghuagui decoction

Development stage: Unknown
Lead developer: Shuguang Hospital
Modality: Small Molecules
Administration: Oral

Overview

Qinghuagui decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Shuguang Hospital, affiliated with the Shanghai University of Chinese Medicine. It is specifically designed for the conservative treatment of non-lactation mastitis (NLM), a condition characterized by chronic breast inflammation not associated with breastfeeding. The decoction aims to alleviate symptoms such as breast lumps, pain, and abscesses by potentially modulating inflammatory responses and improving local microcirculation. It is currently being evaluated in randomized controlled clinical trials to establish its efficacy and safety profile compared to standard conservative treatments.

Other names: Qinghuashi prescription

Beyond the preview

Go deeper on qinghuagui decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on qinghuagui decoction.

Explore the full profile